V018-9270 Screening compound: N-{[3-(2-fluorophenyl)-5-(morpholin-4-yl)-1,2-oxazol-4-yl]methyl}-3-methyl-N-[(oxolan-2-yl)methyl]benzamide

V018-9270 Screening compound: N-{[3-(2-fluorophenyl)-5-(morpholin-4-yl)-1,2-oxazol-4-yl]methyl}-3-methyl-N-[(oxolan-2-yl)methyl]benzamide
V018-9270 Screening compound: N-{[3-(2-fluorophenyl)-5-(morpholin-4-yl)-1,2-oxazol-4-yl]methyl}-3-methyl-N-[(oxolan-2-yl)methyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V018-9270
N-{[3-(2-fluorophenyl)-5-(morpholin-4-yl)-1,2-oxazol-4-yl]methyl}-3-methyl-N-[(oxolan-2-yl)methyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V018-9270

Molecular Formula

C27H30FN3O4 (C27 H30 FN3 O4)

Compound Name

N-{[3-(2-fluorophenyl)-5-(morpholin-4-yl)-1,2-oxazol-4-yl]methyl}-3-methyl-N-[(oxolan-2-yl)methyl]benzamide

IUPAC name

N-{[3-(2-fluorophenyl)-5-(morpholin-4-yl)-12-oxazol-4-yl]methyl}-3-methyl-N-[(oxolan-2-yl)methyl]benzamide

SMILES

Cc1cccc(C(N(CC2OCCC2)Cc2c(N3CCOCC3)onc2-c(cccc2)c2F)=O)c1

InChI

InChI=1S/C27H30FN3O4/c1-19-6-4-7-20(16-19)26(32)31(17-21-8-5-13-34-21)18-23-25(22-9-2-3-10-24(22)28)29-35-27(23)30-11-14-33-15-12-30/h2-4,6-7,9-10,16,21H,5,8,11-15,17-18H2,1H3/t21-/m1/s1

InChI Key

LYJZMZQLNAXFQF-OAQYLSRUSA-N

MDL Number (MFCD)

MFCD19883665

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

479.55

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.416

Distribution Coefficient, logD

3.416

Water Solubility, LogSw

-3.82

Polar Surface Area

59.039

Acid Dissociation Constant (pKa)

22.66

Base Dissociation Constant (pKb)

-3.32

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.70

V018-9270 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V018-9270 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V018-9270?
Check Price and Availability of V018-9270, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V018-9270 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V018-9270
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V018-9270
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V018-9270 available by request